| Literature DB >> 25820656 |
Gongcheng Hu1, Ti Yang1, Jingli Zheng1, Jiabing Dai1, Aruo Nan1, Yandong Lai1, Yajie Zhang2, Chengfeng Yang3, Yiguo Jiang1.
Abstract
Lung cancer is a major health problem, and is considered one of the deadliest cancers in humans. It is refractory to current treatments, and the mechanisms of lung cancer are unknown. Long noncoding RNAs (lncRNAs) are involved in various biological processes and human diseases. However, the exact functional roles and mechanisms of lncRNAs are largely unclear. In this study, we attempted to identify lung-cancer-related lncRNAs. We found changes in lncRNA expression in the anti-benzo(a) pyrene-7,8-diol-9,10-epoxide (anti-BPDE)-transformed human bronchial epithelial cell line (16HBE-T cells) using microarrays and qRT-PCR. Of these lncRNAs, LOC728228 was upregulated relative to its expression in control untransformed16HBE (16HBE-N) cells. LOC728228 knockdown inhibited cell proliferation, caused G0/G1-phase cell-cycle arrest, reduced cellular migration, suppressed colony formation in vitro, and inhibited tumor growth in a nude mouse xenograft model. LOC728228 knockdown also suppressed cyclin D1 expression, and the depletion of cyclin D1 induced G0/G1-phase cell-cycle arrest and inhibited cell proliferation, thus influencing the malignant potential of cancer cells. In summary, our results suggest that lncRNA LOC728228 has an oncogene-like function and plays a vital role in human lung cancer.Entities:
Keywords: 16HBE-T cells; LOC728228; long noncoding RNA; lung cancer
Mesh:
Substances:
Year: 2015 PMID: 25820656 DOI: 10.1002/mc.22314
Source DB: PubMed Journal: Mol Carcinog ISSN: 0899-1987 Impact factor: 4.784